Lorna Speid, B.Pharm.(Hons)., M.R.Pharm.S., Ph.D., RAC is a UK registered Pharmacist, with experience in communicating complex pharmaceutical information for the benefit of patients. Dr. Speid works in the pharmaceutical industry, developing and seeking regulatory approvals for treatments with unmet medical needs.
Dr. Speid has worked for large pharma as well as small biotech companies. These companies include Sanofi Winthrop in the UK (now Sanofi-Aventis), Ciba Geigy and Novartis in Switzerland (at Headquarters). Small companies that she has worked for include GeneMedicine/Valentis, Inc. (Director of Regulatory Affairs), NewBiotics (Vice President Regulatory Affairs and Project Management), and Avera, Inc. (Vice President of Regulatory Affairs). Dr. Speid was an officer at the last two companies.
Dr. Speid’s book, Clinical Trials: What Patients and Healthy Volunteers Need to Know was published by Oxford University Press in 2010, and is being promoted to patients in the US through major bookstores and online. It is also sold in other countries.
Dr. Speid set up a 501(c) (3) non-profit in January 2014 to educate patients with rare diseases, and parents of children with rare diseases, about the clinical trial and drug development processes. This is a very timely initiative because of the increased emphasis in pharma and regulatory circles on patient engagement. The non-profit is called Rare Diseases Patients First! ®, and has been very well received by patients with rare diseases, and parents of children with rare diseases. Collaborators have included patient groups, FDA and several large pharma and biotech companies.